Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 13, 2022
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
Olivia Brayer Initiated (BMRN) at Buy and Held Target at $110 on, Jul 13th, 2022
Olivia Brayer of Cantor Fitzgerald, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy and Held Target at $110 on, Jul 13th, 2022.
Olivia has made no other calls on BMRN in the last 4 months.
There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Olivia's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andreas Argyrides of "Wedbush" Initiated at Hold and Held Target at $70 on, Monday, June 13th, 2022
These are the ratings of the 2 analyists that currently disagree with Olivia
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $106 on, Monday, June 6th, 2022
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $113 on, Monday, April 25th, 2022
